Australia markets close in 4 hours 18 minutes

Entheon Biomedical Corp. (ENTBF)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.09650.0000 (0.00%)
At close: 10:40AM EDT

Entheon Biomedical Corp.

999 West Broadway
Suite 720
Vancouver, BC V5Z 1K5

Full-time employees1

Key executives

NameTitlePayExercisedYear born
Mr. Timothy KoPresident, CEO & Director55.31kN/A1986
Mr. Soo-Whan KimInterim Chief Financial Officer26.61kN/AN/A
Dr. Brian E. Jahns Pharm.D.Chief Business OfficerN/AN/AN/A
Ms. Kelly PladsonCorporate SecretaryN/AN/A1983
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada.

Corporate governance

Entheon Biomedical Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.